Mahaney Paige bought CCCC
February 14, 2026 · Form 4 insider transaction
Mahaney Paige bought 7,050 shares of C4 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,050
Price
$0.00
Total value
N/A
InsiderMahaney Paige
RoleOfficer
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 14, 2026
Filing dateFebruary 18, 2026
Shares owned after339,356
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of RSUs. The grant of RSUs was initially reported in Table I of the Forms 4 filed by the Reporting Person on February 18, 2025.